| Literature DB >> 24503976 |
Caitlin E Holtby1, Judith R Guernsey2, Alexander C Allen3, John A Vanleeuwen4, Victoria M Allen5, Robert J Gordon6.
Abstract
Animal studies and epidemiological evidence suggest an association between prenatal exposure to drinking water with elevated nitrate (NO3-N) concentrations and incidence of congenital anomalies. This study used Geographic Information Systems (GIS) to derive individual-level prenatal drinking-water nitrate exposure estimates from measured nitrate concentrations from 140 temporally monitored private wells and 6 municipal water supplies. Cases of major congenital anomalies in Kings County, Nova Scotia, Canada, between 1988 and 2006 were selected from province-wide population-based perinatal surveillance databases and matched to controls from the same databases. Unconditional multivariable logistic regression was performed to test for an association between drinking-water nitrate exposure and congenital anomalies after adjusting for clinically relevant risk factors. Employing all nitrate data there was a trend toward increased risk of congenital anomalies for increased nitrate exposure levels though this was not statistically significant. After stratification of the data by conception before or after folic acid supplementation, an increased risk of congenital anomalies for nitrate exposure of 1.5-5.56 mg/L (2.44; 1.05-5.66) and a trend toward increased risk for >5.56 mg/L (2.25; 0.92-5.52) was found. Though the study is likely underpowered, these results suggest that drinking-water nitrate exposure may contribute to increased risk of congenital anomalies at levels below the current Canadian maximum allowable concentration.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24503976 PMCID: PMC3945569 DOI: 10.3390/ijerph110201803
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Descriptive statistics of nitrate-nitrogen concentrations (mg/L) for all water sources in each municipal water supply from 1996 to 2003 in comparison to all sampled rural wells in Kings County from 1999–2000. Nitrate exposure level refers to the nitrate concentration categorization used in subsequent analyses to determine the association between congenital anomalies and nitrate exposure.
| Location | Water Source | # of Sample Locations | Total # of Samples | Min. [Nitrate] | Max. [Nitrate] | Mean [Nitrate] * | Median [Nitrate) | Nitrate Exposure Level |
|---|---|---|---|---|---|---|---|---|
| All rural wells | Groundwater | 140 | 1,113 | 0.0 | 43.0 | 6.44 | 3.8 | n/a |
| All municipalities | Ground and surface water | 20 | 53 | 0.0 | 10.4 | 2.03 | 1.7 | n/a |
| Canning | Groundwater | 2 | 24 | 1.0 | 2.5 | 1.63 | 1.7 | 1.0–5.56 |
| Greenwood | Groundwater | 2 | 5 | 0.0 | 1.0 | 0.63 | 0.9 | <1.0 |
| Kentville | Surfacewater | 1 | 2 | 0.4 | 1.0 | 0.69 | 0.7 | <1.0 |
| New Minas | Groundwater | 9 | 10 | 1.0 | 2.9 | 1.68 | 1.6 | 1.0–5.56 |
| Port Williams | Groundwater | 4 | 6 | 1.4 | 10.4 | 5.08 | 4.6 | 1.0–5.56 |
| Wolfville | Groundwater | 2 | 6 | 2.4 | 3.6 | 2.77 | 2.7 | 1.0–5.56 |
Note: * 95% CI.
Figure 1Map of Kings County, Nova Scotia, highlighting the six small town municipal water supplies and the locations of the rural wells from which nitrate concentrations were monitored in 1999 and 2000.
Figure 2Map showing the drinking-water nitrate exposure estimates for Kings County, Nova Scotia, that were derived using ordinary kriging and extrapolation estimates in rural areas and statistically derived estimates of average nitrate concentrations in municipal water supplied regions.
Frequency of diagnoses of major congenital anomalies in Kings County, categorized by body system, over the entire study period (1987–2006), during the period prior to the fortification of food in Canada with folate (1987–1997), and for the period after folate fortification (1998–2006) *.
| Class of Anomaly | Entire Study Period | Before Folate Fortification | After Folate Fortification | |||
|---|---|---|---|---|---|---|
| 1987–2006 | 1987–997 | 1998–2006 | ||||
| Number of cases | Percentage of all congenital anomalies | Number of cases | Percentage of all congenital anomalies for period | Number of cases | Percentage of all congenital anomalies for period | |
| All Anomalies | 606 | 100 | 300 | 100 | 306 | 100 |
| Central Nervous System | 286 | 47 | 98 | 33 | 188 | 61 |
| Musculoskeletal System | 101 | 17 | 58 | 19 | 43 | 14 |
| Genitourinary System | 50 | 8 | 25 | 8 | 25 | 8 |
| Cardiovascular System | 47 | 8 | 26 | 9 | 21 | 7 |
| Inguinal Canal | 37 | 6 | 26 | 9 | 11 | 4 |
| Multiple Anomalies | 33 | 5 | 24 | 8 | 9 | 3 |
| Eye, Ear, Nose, Throat and Mouth | 27 | 4 | 17 | 6 | 10 | 3 |
| Other | 27 | 3 | 16 | 5 | 11 | 4 |
| Missing | 53 | 9 | 53 | 18 | 0 | 0 |
Note: * All categories containing fewer than five cases were amalgamated.
Distribution of matching, demographic, health and water source variables, including nitrate exposure level, between cases of congenital anomalies and controls, as well as univariable logistic regression odds ratios between incidence of congenital anomalies and all variables for cases and controls (1987–2006).
| Variable | Cases (n = 606) | Controls (n = 1,635) | Crude Odds Ratio ** | |||
|---|---|---|---|---|---|---|
| n | % | n | % | |||
| Sex | 0.91 | |||||
| Female | 268 | 48 | 788 | 48 | 1.0 | |
| Male | 285 | 52 | 847 | 52 | 0.99 (0.82–1.20) | |
| Missing | 53 | 0 | ||||
| Season of conception | 0.96 | |||||
| Winter | 83 | 14 | 244 | 15 | 1.0 | |
| Spring | 139 | 15 | 393 | 24 | 1.04 (0.76–1.43) | 0.63 |
| Summer | 162 | 25 | 484 | 30 | 0.98 (0.73–1.34) | 0.87 |
| Fall | 169 | 29 | 514 | 31 | 0.97 (0.71–1.31) | 0.70 |
| Missing | 53 | 0 | ||||
| Year of Conception | ||||||
| 1987–1991 | 83 | 15 | 245 | 15 | 1.0 | |
| 1992–1996 | 113 | 20 | 342 | 21 | 0.98 (0.70–1.35) | 0.75 |
| 1997–2001 | 282 | 51 | 838 | 51 | 0.99 (0.75–1.32) | 0.87 |
| 2002–2006 | 75 | 14 | 210 | 13 | 1.05 (0.73–1.52) | 0.67 |
| Missing | 53 | 0 | ||||
| Parity | ||||||
| 0 | 273 | 49 | 687 | 42 | 1.0 | |
| 1–2 | 252 | 46 | 852 | 52 | 0.29 | |
| 3+ | 28 | 5 | 96 | 6 | 0.73 (0.47–1.14) | 0.46 |
| Missing | 53 | 0 | ||||
| Pre-pregnancy weight (kg) | 0.55 | |||||
| <50 | ||||||
| 50–69 | 44 | 9 | 129 | 9 | 1.02 (0.70–1.47) | 0.68 |
| ≥70 | 281 | 59 | 837 | 56 | 1.0 | |
| Missing | 155 | 32 | 520 | 35 | 0.89 (0.71–1.11) | 0.33 |
| 126 | 149 | |||||
| Smoker | ||||||
| No | 358 | 59 | 1140 | 70 | 1.0 | |
| Yes | 248 | 41 | 495 | 30 | ||
| Thyroid | ||||||
| No | 604 | 1,626 | 99 | 1.0 | ||
| Yes | 2 | 100 | 9 | 1 | 0.60 (0.13–2.78) | 0.51 |
| Folate supplementation | ||||||
| No | 111 | 58 | 317 | 57 | 1.0 | 0.74 |
| Yes | 79 | 42 | 239 | 43 | 0.94 (0.67–1.32) | 0.74 |
| Missing | 416 | 1,079 | ||||
| Folate Fortification | ||||||
| No | 300 | 50 | 740 | 45 | 1.0 | |
| Yes | 306 | 50 | 895 | 55 | 0.84 (0.70–1.02) | 0.07 |
| Water source | ||||||
| Surface | 118 | 19 | 304 | 19 | 1.0 | |
| Ground | 488 | 81 | 1,331 | 81 | 0.95 (0.75–1.20) | 0.64 |
| Municipal water | ||||||
| Yes | 245 | 40 | 609 | 37 | 1.0 | |
| No | 361 | 60 | 1,026 | 63 | 0.88 (0.72–1.06) | 0.17 |
| Nitrate exposure level | ||||||
| <1 mg/L | 127 | 21 | 353 | 22 | 1.0 | |
| 1–5.56 mg/L | 351 | 58 | 931 | 57 | 1.02 (0.81–1.30) | 0.68 |
| >5.56 mg/L | 127 | 21 | 351 | 21 | 0.97 (0.73–1.29) | 0.71 |
Notes: * The values listed across from the variable names represent the p-values for the entire model. The p-values listed across from each category within variables represent the p-values for that category. ** 95% CI.
The progressive generation of the final multivariable logistic regression model describing the incidence of congenital anomalies by nitrate exposure level in a stepwise fashion such that potential confounding variables are added to the model one group at a time for all data from 1987–2006.
| Variable | Basic Model: Matching Variables | Basic Model Plus Maternal Demographic Variables | Basic Model Plus Maternal Demographic and Health Variables | Basic Model Plus Maternal Demographic, Health and Water Source Variables | Final Model: Effect of Nitrate Exposure Level on Congenital Anomalies after Controlling for All Other Variables |
|---|---|---|---|---|---|
| Sex | |||||
| Female | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Male | 0.99 (0.82–1.20) | 0.99 (0.82–1.21) | 0.98 (0.81–1.20) | 0.99 (0.81–1.20) | 0.98 (0.81–1.20) |
| Season of conception | |||||
| Winter | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Spring | 1.04 (0.76–1.43) | 1.05 (0.76–1.44) | 1.05 (0.76–1.44) | 1.05 (0.76–1.44) | 1.05 (0.76–1.44) |
| Summer | 0.97 (0.72–1.34) | 0.99 (0.72–1.34) | 1.00 (0.73–1.37) | 1.00 (0.74–1.37) | 1.00 (0.74–1.37) |
| Fall | 0.97 (0.72–1.32) | 0.96 (0.72–1.27) | 0.97 (0.71–1.32) | 0.97 (0.71–1.32) | 0.98 (0.72–1.33) |
| Year of conception | |||||
| 1987–1991 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| 1992–1996 | 0.98 (0.71–1.36) | 0.97 (0.70–1.36) | 0.98 (0.71–1.37) | 0.99 (0.71–1.38) | 0.99 (0.71–1.38) |
| 1997–2001 | 1.00 (0.71–1.36) | 0.96 (0.72–1.27) | 0.97 (0.73–1.29) | 0.98 (0.74–1.31) | 1.00 (0.75–1.34) |
| 2002–2006 | 1.05 (0.73–1.51) | 1.02 (0.70–1.45) | 1.02 (0.71–1.48) | 1.03 (0.72–1.49) | 1.05 (0.72–1.52) |
| Maternal age | |||||
| <20 | 1.01 (0.71–1.44) | 0.94 (0.66–1.35) | 0.94 (0.66–1.35) | 0.95 (0.66–1.36) | |
| 20–34 | 1.0 | 1.0 | 1.0 | 1.0 | |
| ≥35 | |||||
| Parity | |||||
| 0 | 1.0 | 1.0 | 1.0 | 1.0 | |
| 1–2 | |||||
| 3+ | 0.68 (0.43–1.07) | 0.67 (0.43–1.06) | 0.68 (0.43–1.07) | 0.70 (0.43–1.06) | |
| Smoker | |||||
| No | 1.0 | 1.0 | 1.0 | ||
| Yes | |||||
| Diabetes | |||||
| No | 1.0 | 1.0 | 1.0 | ||
| Gestational | 1.30 (0.70–2.41) | 1.29 (0.70–2.40) | 1.31 (0.71–2.44) | ||
| Other diabetes | 0.97 (0.34–2.73) | 0.97 (0.34–2.73) | 0.96 (0.34–2.70) | ||
| Thyroid disease | |||||
| No | 1.0 | 1.0 | 1.0 | ||
| Yes | 0.64 (0.14–3.00) | 0.65 (0.14–3.05) | 0.64 (0.14–3.01) | ||
| Water source | |||||
| Surface | 1.0 | 1.0 | |||
| Ground | 0.85 (0.66–1.09) | 0.70 (0.35–1.41) | |||
| Municipal water | |||||
| Yes | 1.0 | 1.0 | |||
| No | 1.10 (0.81–1.51) | 0.82 (0.63–1.07) | |||
| Nitrate exposure level | |||||
| <1 mg/L | 1.0 | ||||
| 1–5.56 mg/L | 1.65 (0.83–3.27) | ||||
| >5.56 mg/L | 1.66 (0.81–3.42) |
Final adjusted multivariate associations between incidence of congenital anomalies and all variables, including nitrate exposure level for cases and controls stratified by date of conception prior to or after 1998, when folic acid fortification was introduced to Nova Scotia.
| Variable | Cases and Controls Conceived from 1987–1997 | Cases and Controls Conceived from 1998–2006 |
|---|---|---|
| Sex | ||
| Female | 1.0 | 1.0 |
| Male | 1.0 (0.75–1.34) | 0.96 (0.73–1.24) |
| Season of conception | ||
| Winter | 1.0 | 1.0 |
| Spring | 1.0 (0.61–1.63) | 1.12 (0.73–1.71) |
| Summer | 1.01 (0.62–1.63) | 1.01 (0.67–1.53) |
| Fall | 0.98 (0.62–1.55) | 0.98 (0.64–1.50) |
| Year of conception | ||
| 1987–1991 | 1.0 | – |
| 1992–1996 | 0.96 (0.69–1.35) | – |
| 1997–2001 | 0.94 (0.62–1.42) | 1.0 |
| 2002–2006 | – | 1.02 (0.75–1.39) |
| Maternal age | ||
| <20 | 0.85 (0.50–1.43) | 1.01 (0.61–1.68) |
| 20–34 | 1.0 | 1.0 |
| ≥35 | 1.35 (0.76–2.39) | 1.50 (1.03–2.19) |
| Parity | ||
| 0 | 1.0 | 1.0 |
| 1–2 | 0.77 (0.56–1.05) | |
| 3+ | 0.75 (0.39–1.45) | 0.59 (0.31–1.11) |
| Smoker | ||
| No | 1.0 | 1.0 |
| Yes | 1.01 (0.74–1.38) | |
| Thyroid disease | ||
| No | 1.0 | 1.0 |
| Yes | 1.55 (0.13–18.10) | 0.36 (0.04–3.01) |
| Diabetes | ||
| No | 1.0 | 1.0 |
| Gestational | 1.63 (0.73–3.64) | 2.27 (0.30–16.71) |
| Other diabetes | 0.49 (0.06–4.15) | – |
| Water source | ||
| Surface | 1.0 | 1.0 |
| Ground | 2.50 (0.62–10.08) | 0.54 (0.23–1.29) |
| Municipal | ||
| Yes | 1.0 | 1.0 |
| No | 0.78 (0.53–1.14) | 0.82 (0.56–1.20) |
| Nitrate Exposure level | ||
| <1 mg/L | 1.0 | 1.0 |
| 1–5.56 mg/L | 0.48 (0.10–1.60) | |
| >5.56 mg/L | 0.47 (0.11–1.90) | 2.25 (0.92–5.52) |